Kirilys Therapeutics is a multi-asset precision oncology company developing targeted therapeutic treatments for cancer patients. Led by co-founder and CEO BT Slingsby, MD, PhD, MPH, the company is building a pipeline of precision medicines and is backed by Catalys Pacific, Lightspeed Venture Partners, and UBE. - View it on GitHub